Corrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis.

MASH MASLD gasdermins liver pyroptosis steatohepatitis steatotic liver disease

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2024
Historique:
received: 08 07 2024
accepted: 10 07 2024
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 31 10 2024
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fcell.2023.1218807.].

Identifiants

DOI: 10.3389/fcell.2024.1461581 PMID: 39479516 PMC: PMC11522226
pubmed: 39479516
doi: 10.3389/fcell.2024.1461581
pii: 1461581
pmc: PMC11522226
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1461581

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2024 Stoess, Leszczynska, Kui and Feldstein.

Auteurs

Christian Stoess (C)

Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA, United States.
Department of Surgery, TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Aleksandra Leszczynska (A)

Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA, United States.

Lin Kui (L)

Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA, United States.

Ariel E Feldstein (AE)

Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA, United States.

Classifications MeSH